Why the study?
Does ACE inhibitor therapy cause irreversible deterioration in renal function in patients with vascular disease or preexisting renal impairment?
Does ACE inhibitor therapy cause irreversible deterioration in renal function in patients with vascular disease or preexisting renal impairment?
Deterioration in renal function following ACE inhibitor initiation is not always reversible, highlighting the need for extreme caution in patients with likely atherosclerotic vascular disease.
Answers are grounded in this paper and cite their sources.
May cause irreversible renal failure after ACE inhibitor start in high-risk patients; case reports leave open incidence and causality.
Fifteen patients presented between January 1986 and January 1991 with deterioration in renal function coincident with the introduction of angiotensin converting enzyme inhibitors. There was evidence of extrarenal vascular disease in 12 patients and preexisting renal impairment in 13. Four patients remained dialysis-dependent and died within 4 weeks of presentation. Five patients required short-term dialysis. Serum creatinine remained above pre-treatment values in seven patients. Conventional explanations of the decline in renal function with ACE inhibition do not account for irreversible decrements in renal function. Possible mechanisms for this observation and clinical guidelines to identify patients at risk are suggested. We conclude that these agents should be used with great care in patients in whom atherosclerotic vascular disease is likely.
No takes yet. Share an insight, caveat, or question.
Devoy et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: